| Type of Sickle | Total | |||||
Hb SB + thalassemia | Hb SB 0-thalassemia | Hb SC | Hb SS | SCT | |||
Delay Phase | Well defined enhanced lesion | - | - | 1 (3.1%) | 1 (3.1%) | 1 (3.1%) | 3 (9.4%) |
Well defined hypo dense lesion | - | 3 (9.4%) | 3 (9.4%) | 12 (37.5%) | - | 18 (56.3%) | |
Well defined peripheral enhance with unenhanced hypo dense lesion | - | - | - | 2 (6.3%) | - | 2 (6.3%) | |
Ill defined unenhanced lesion | 1 (3.1%) | - | 2 (6.3%) | 1 (3.1%) | - | 4 (12.5%) | |
Washout CM (not seen) | 1 (3.1%) | 2 (6.3%) | - | 2 (6.3%) | - | 5 (15.6%) | |
Total | 2 (6.3%) | 5 (15.6%) | 6 (18.8%) | 18 (56.3%) | 1 (3.1%) | 32 (100.0%) | |
P-value = 0.055 |